Drug Type Gene editing |
Synonyms- |
Target |
Action modulators |
Mechanism ATP1A3 modulators(Sodium/potassium-transporting ATPase subunit alpha-3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alternating Hemiplegia of Childhood | Preclinical | United States | 21 Jul 2025 | |
Alternating Hemiplegia of Childhood | Preclinical | United States | 21 Jul 2025 |